Use of gp120-CD4-coreceptor fusion complexes and CD4-independent gp120s for the induction of HIV-1 neutralizing antibodies
Andrea Matucci(Ospedale Sacro Cuore Don Calabria), Donato Zipeto(University of Verona), Gabriella Scarlatti(Istituti di Ricovero e Cura a Carattere Scientifico), Lucia Lopalco(Vita-Salute San Raffaele University), Paola Rossolillo(University of Verona), Umberto Bertazzoni(University of Verona), Uriel Hazan, Carla Ripamonti(University of Brescia)
Unknown
January 1, 2005
Cited by 0
Related Papers
Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines
|Annals of Oncology|2018|874
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
|Nature Medicine|1997|635
Control of HIV despite the Discontinuation of Antiretroviral Therapy
|New England Journal of Medicine|1999|328